CA2268886A1 - Aminothiophenecarboxamides - Google Patents
AminothiophenecarboxamidesInfo
- Publication number
- CA2268886A1 CA2268886A1 CA002268886A CA2268886A CA2268886A1 CA 2268886 A1 CA2268886 A1 CA 2268886A1 CA 002268886 A CA002268886 A CA 002268886A CA 2268886 A CA2268886 A CA 2268886A CA 2268886 A1 CA2268886 A1 CA 2268886A1
- Authority
- CA
- Canada
- Prior art keywords
- aminothiophenecarboxamides
- phosphodiesterase
- potency
- disturbances
- demonstrate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D333/38—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
- C07D333/62—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
- C07D333/68—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Heart & Thoracic Surgery (AREA)
- Gynecology & Obstetrics (AREA)
- Cardiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Aminothiophene carboxylic acid amides having formula (I) and their physiologically harmless salts, wherein R1, R2, R3, R4, R5, A and n have the meaning given in claim 1, demonstrate phosphodiesterase V inhibition and can be used to treat cardiovascular diseases and in therapy for disturbances of potency.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19642451A DE19642451A1 (en) | 1996-10-15 | 1996-10-15 | Aminothiophene carboxamides |
DE19642451.8 | 1996-10-15 | ||
PCT/EP1997/005531 WO1998016521A1 (en) | 1996-10-15 | 1997-10-08 | Aminothiophene carboxylic acid amides and the use thereof as phosphodiesterase inhibitors |
Publications (2)
Publication Number | Publication Date |
---|---|
CA2268886A1 true CA2268886A1 (en) | 1998-04-23 |
CA2268886C CA2268886C (en) | 2008-05-20 |
Family
ID=7808775
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002268886A Expired - Fee Related CA2268886C (en) | 1996-10-15 | 1997-10-08 | Aminothiophenecarboxamides |
Country Status (26)
Country | Link |
---|---|
US (1) | US6143777A (en) |
EP (1) | EP0934301B1 (en) |
JP (1) | JP4243352B2 (en) |
KR (1) | KR100479811B1 (en) |
CN (1) | CN1110493C (en) |
AR (1) | AR009985A1 (en) |
AT (1) | ATE202347T1 (en) |
AU (1) | AU725741B2 (en) |
BR (1) | BR9712321A (en) |
CA (1) | CA2268886C (en) |
CZ (1) | CZ297253B6 (en) |
DE (2) | DE19642451A1 (en) |
DK (1) | DK0934301T3 (en) |
ES (1) | ES2159851T3 (en) |
GR (1) | GR3036341T3 (en) |
HK (1) | HK1020724A1 (en) |
HU (1) | HUP9904703A3 (en) |
NO (1) | NO991776L (en) |
PL (1) | PL192109B1 (en) |
PT (1) | PT934301E (en) |
RU (1) | RU2184731C2 (en) |
SI (1) | SI0934301T1 (en) |
SK (1) | SK283807B6 (en) |
TW (1) | TW438791B (en) |
WO (1) | WO1998016521A1 (en) |
ZA (1) | ZA979199B (en) |
Families Citing this family (37)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6727258B2 (en) * | 1997-10-29 | 2004-04-27 | King Pharmaceutical Research & Development, Inc. | Allosteric adenosine receptor modulators |
US6410584B1 (en) | 1998-01-14 | 2002-06-25 | Cell Pathways, Inc. | Method for inhibiting neoplastic cells with indole derivatives |
JP2002518471A (en) * | 1998-06-19 | 2002-06-25 | ノバルティス アクチエンゲゼルシャフト | Preparation of pyrimidinone derivatives |
US6200771B1 (en) | 1998-10-15 | 2001-03-13 | Cell Pathways, Inc. | Method of using a novel phosphodiesterase in pharmaceutical screeing to identify compounds for treatment of neoplasia |
US6133271A (en) * | 1998-11-19 | 2000-10-17 | Cell Pathways, Inc. | Method for inhibiting neoplastic cells and related conditions by exposure thienopyrimidine derivatives |
US6187779B1 (en) | 1998-11-20 | 2001-02-13 | Cell Pathways, Inc. | Method for inhibiting neoplastic cells and related conditions by exposure to 2,8-disubstituted quinazoline derivatives |
US6369092B1 (en) | 1998-11-23 | 2002-04-09 | Cell Pathways, Inc. | Method for treating neoplasia by exposure to substituted benzimidazole derivatives |
US6486155B1 (en) | 1998-11-24 | 2002-11-26 | Cell Pathways Inc | Method of inhibiting neoplastic cells with isoquinoline derivatives |
US6034099A (en) * | 1998-11-24 | 2000-03-07 | Cell Pathways, Inc. | Method for inhibiting neoplastic lesions by administering 4-(arylmethylene)- 2, 3- dihydro-pyrazol-3-ones |
US6077842A (en) * | 1998-11-24 | 2000-06-20 | Cell Pathways, Inc. | Method of inhibiting neoplastic cells with pyrazolopyridylpyridazinone derivatives |
US6020379A (en) * | 1999-02-19 | 2000-02-01 | Cell Pathways, Inc. | Position 7 substituted indenyl-3-acetic acid derivatives and amides thereof for the treatment of neoplasia |
US6479493B1 (en) | 2001-08-23 | 2002-11-12 | Cell Pathways, Inc. | Methods for treatment of type I diabetes |
WO2003027093A1 (en) * | 2001-09-21 | 2003-04-03 | Smithkline Beecham Corporation | Chemical compounds |
DE60229975D1 (en) * | 2001-10-04 | 2009-01-02 | Smithkline Beecham Corp | NF-KB INHIBITORS |
US7208516B2 (en) | 2002-03-20 | 2007-04-24 | Celgene Corporation | Methods of the treatment of psoriatic arthritis using (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione |
US6962940B2 (en) | 2002-03-20 | 2005-11-08 | Celgene Corporation | (+)-2-[1-(3-Ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione: methods of using and compositions thereof |
US7893101B2 (en) | 2002-03-20 | 2011-02-22 | Celgene Corporation | Solid forms comprising (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione, compositions thereof, and uses thereof |
US7276529B2 (en) | 2002-03-20 | 2007-10-02 | Celgene Corporation | Methods of the treatment or prevention of exercise-induced asthma using (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione |
US7196207B2 (en) * | 2002-07-24 | 2007-03-27 | Mitsui Chemicals, Inc. | Method for producing 2-alkyl-3-aminothiophene derivative |
US7179836B2 (en) * | 2002-09-20 | 2007-02-20 | Smithkline Beecham Corporation | Chemical compounds |
FR2875807B1 (en) | 2004-09-30 | 2006-11-17 | Servier Lab | ALPHA CRYSTALLINE FORM OF STRONTIUM RANELATE, PROCESS FOR PREPARING THE SAME, AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME |
EP2258357A3 (en) | 2005-08-26 | 2011-04-06 | Braincells, Inc. | Neurogenesis with acetylcholinesterase inhibitor |
JP2009506069A (en) | 2005-08-26 | 2009-02-12 | ブレインセルス,インコーポレイティド | Neurogenesis through modulation of muscarinic receptors |
AU2006304787A1 (en) | 2005-10-21 | 2007-04-26 | Braincells, Inc. | Modulation of neurogenesis by PDE inhibition |
US20070112017A1 (en) | 2005-10-31 | 2007-05-17 | Braincells, Inc. | Gaba receptor mediated modulation of neurogenesis |
US20100216734A1 (en) | 2006-03-08 | 2010-08-26 | Braincells, Inc. | Modulation of neurogenesis by nootropic agents |
JP2009536667A (en) | 2006-05-09 | 2009-10-15 | ブレインセルス,インコーポレイティド | 5HT receptor-mediated neurogenesis |
EP2021000A2 (en) | 2006-05-09 | 2009-02-11 | Braincells, Inc. | Neurogenesis by modulating angiotensin |
US7998971B2 (en) * | 2006-09-08 | 2011-08-16 | Braincells Inc. | Combinations containing a 4-acylaminopyridine derivative |
US20100184806A1 (en) | 2006-09-19 | 2010-07-22 | Braincells, Inc. | Modulation of neurogenesis by ppar agents |
MX2011002149A (en) * | 2008-08-27 | 2011-04-05 | Calcimedica Inc | Compounds that modulate intracellular calcium. |
WO2010099217A1 (en) | 2009-02-25 | 2010-09-02 | Braincells, Inc. | Modulation of neurogenesis using d-cycloserine combinations |
US20150119399A1 (en) | 2012-01-10 | 2015-04-30 | President And Fellows Of Harvard College | Beta-cell replication promoting compounds and methods of their use |
RU2503671C1 (en) * | 2012-07-31 | 2014-01-10 | Федеральное государственное бюджетное образовательное учреждение высшего профессионального образования "Пермский государственный национальный исследовательский университет" | (Z)-2-[(3-CARBAMOYL-4,5,6,7-TETRAHYDROBENZO[b]THIEN-2-YL)AMINO]-4-(4-R-PHENYL)-4-OXOBUT-2-ENOIC ACIDS, HAVING ANALGESIC ACTIVITY |
RU2501795C1 (en) * | 2012-10-01 | 2013-12-20 | Федеральное государственное бюджетное образовательное учреждение высшего профессионального образования "Пермский государственный национальный исследовательский университет" | N-R-AMIDES OF (Z)-2[(3-ETHOXYCARBONYL)-4,5,6,7-TETRAHYDROBENZO [b]THIEN-2-YL)AMINO]-4-PHENYL-4-OXOBUT-2-ENOIC ACIDS, HAVING ANALGESIC ACTIVITY |
EP3157520B1 (en) | 2014-06-23 | 2019-09-04 | Celgene Corporation | Apremilast for the treatment of a liver disease or a liver function abnormality |
RU2722176C1 (en) * | 2019-09-06 | 2020-05-28 | Федеральное государственное бюджетное образовательное учреждение высшего образования "Пермский государственный национальный исследовательский университет" | (z)-2-((4-r1-5-r2-3-(ethoxycarbonyl)thiophen-2-yl)amino)-4-oxo-4-r3-but-2-ene acids, having antimicrobial activity |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5075310A (en) * | 1988-07-01 | 1991-12-24 | Smith Kline & French Laboratories, Ltd. | Pyrimidone derivatives as bronchodilators |
US5753692A (en) * | 1992-02-19 | 1998-05-19 | Industrial Technology Research Institute | Medicinal thiophene compounds |
US5356926A (en) * | 1992-02-24 | 1994-10-18 | Warner-Lambert Company | 3-alkyloxy-, aryloxy-, or arylalkyloxy-benzo [β]thiophene-2-carboxamides as inhibitors of cell adhesion |
DE4230755A1 (en) * | 1992-09-14 | 1994-03-17 | Schering Ag | Phosphodiesterase IV inhibitors for kidney and ureter disease treatment - with eg (4-(3-(cyclopentyl oxy) 4-methoxyphenyl-2-pyrrolidinone) being specific for kidney and ureter tissue relaxation |
DK148292D0 (en) * | 1992-12-09 | 1992-12-09 | Lundbeck & Co As H | RELATIONS |
GB9309324D0 (en) * | 1993-05-06 | 1993-06-16 | Bayer Ag | Venzofuranyl-and-thiophenyl-alkanecarboxyclic acids derivatives |
DE4317076A1 (en) * | 1993-05-21 | 1994-11-24 | Bayer Ag | Benzothiophene carboxamide S-oxide |
ES2127966T3 (en) * | 1994-05-31 | 1999-05-01 | Bayer Ag | DERIVATIVES OF AMINO-BENZOFURILO AND -BENZOTIENILO. |
US5863936A (en) * | 1995-04-18 | 1999-01-26 | Geron Corporation | Telomerase inhibitors |
CA2268164A1 (en) * | 1996-10-08 | 1998-04-16 | Yao-Chang Xu | New serotonin 5-ht1f agonists |
US5783597A (en) * | 1997-03-04 | 1998-07-21 | Ortho Pharmaceutical Corporation | 2,5-disubstituted thiophenes: inhibitors of 5-lipoxygenase and inducible cyclooxygenase (COX-2) enzymes, composition and use |
-
1996
- 1996-10-15 DE DE19642451A patent/DE19642451A1/en not_active Withdrawn
-
1997
- 1997-10-06 TW TW086114589A patent/TW438791B/en active
- 1997-10-08 DE DE59703869T patent/DE59703869D1/en not_active Expired - Lifetime
- 1997-10-08 CA CA002268886A patent/CA2268886C/en not_active Expired - Fee Related
- 1997-10-08 DK DK97912140T patent/DK0934301T3/en active
- 1997-10-08 AT AT97912140T patent/ATE202347T1/en not_active IP Right Cessation
- 1997-10-08 SI SI9730192T patent/SI0934301T1/en unknown
- 1997-10-08 ES ES97912140T patent/ES2159851T3/en not_active Expired - Lifetime
- 1997-10-08 RU RU99109576/04A patent/RU2184731C2/en not_active IP Right Cessation
- 1997-10-08 CN CN97198839A patent/CN1110493C/en not_active Expired - Fee Related
- 1997-10-08 KR KR10-1999-7003246A patent/KR100479811B1/en not_active IP Right Cessation
- 1997-10-08 PL PL332802A patent/PL192109B1/en unknown
- 1997-10-08 EP EP97912140A patent/EP0934301B1/en not_active Expired - Lifetime
- 1997-10-08 US US09/284,501 patent/US6143777A/en not_active Expired - Fee Related
- 1997-10-08 AU AU49451/97A patent/AU725741B2/en not_active Ceased
- 1997-10-08 PT PT97912140T patent/PT934301E/en unknown
- 1997-10-08 WO PCT/EP1997/005531 patent/WO1998016521A1/en active IP Right Grant
- 1997-10-08 BR BR9712321-8A patent/BR9712321A/en not_active Application Discontinuation
- 1997-10-08 CZ CZ0124099A patent/CZ297253B6/en not_active IP Right Cessation
- 1997-10-08 JP JP51798698A patent/JP4243352B2/en not_active Expired - Fee Related
- 1997-10-08 HU HU9904703A patent/HUP9904703A3/en unknown
- 1997-10-08 SK SK432-99A patent/SK283807B6/en unknown
- 1997-10-14 ZA ZA9709199A patent/ZA979199B/en unknown
- 1997-10-15 AR ARP970104736A patent/AR009985A1/en not_active Application Discontinuation
-
1999
- 1999-04-14 NO NO991776A patent/NO991776L/en not_active Application Discontinuation
- 1999-11-04 HK HK99105058A patent/HK1020724A1/en not_active IP Right Cessation
-
2001
- 2001-08-07 GR GR20010401193T patent/GR3036341T3/en not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2268886A1 (en) | Aminothiophenecarboxamides | |
CA2269815A1 (en) | Thienopyrimidines having pde v-inhibiting action | |
MY110110A (en) | Pharmaceuticals in the treatment of gastrointestinal disorders, cardiovascular disorders and cns disorders | |
CA2263561A1 (en) | Thienopyrimidines | |
CA2311922A1 (en) | Thienopyrimidines | |
MX9803753A (en) | CYCLIC AND HETEROCYCLIC N-SUBSTITUTED 'alpha'-IMINOHYDROXAMIC AND CARBOXYLIC ACIDS. | |
MY103352A (en) | Piperazinyl-heterocyclic compounds | |
CA2181175A1 (en) | Dihydro Pyrazolopyrroles | |
AP2002002637A0 (en) | Novel piperazine | |
NZ335146A (en) | N-(N'-substituted glycyl)-2-cyanopyrrolidine derivatives and medicaments | |
ZA975323B (en) | Use of strontium salts for the production of pharmaceutical compositions intended for the treatment of arthrosis. | |
WO2003089434A3 (en) | IMIDAZO[1,2-a]PYRAZIN-8-YLAMINES METHOD OF MAKING AND METHOD OF USE THEREOF | |
CA2196995A1 (en) | Spiro-azabicyclic compounds useful in therapy | |
CA2263417A1 (en) | Arylalkanoylpyridazines | |
HK1011987A1 (en) | Sulfonamidocarbonylpyridine-2-carboxamides and their use as medicines | |
CA2167524A1 (en) | Topically administrable compositions containing 3-benzoylphenylacetic acid derivatives for treatment of ophthalmic inflammatory disorders | |
AU3481593A (en) | N-(3-phenylpropyl)oxamic acid, oxamate, and oxamide derivatives | |
MY102323A (en) | New ribofuranuronic acid derivatives | |
UA43317C2 (en) | Aromatic carboxylic acid derivatives and a pharmaceutical composition | |
ES2058029A1 (en) | Process for the production of clavulanic acid salts | |
MY103210A (en) | Arylpiperazinyl-alkylene-phenyl-heterocyclic compounds. | |
CA2168193A1 (en) | Aryalkyl-thiadiazinones | |
HU9403383D0 (en) | Diamine salts of clavulanic acid | |
NO20003784L (en) | Process for the preparation of enansiomerically pure cycloalkanoindolecarboxylic acid and azaindolecarboxylic acids and pyrimido 1,2a indolecarboxylic acids and derivatives thereof | |
TW349864B (en) | Use of N-(pyridinyl)-1H-indol-a-amines for the preparation of a medicament for the treatment of obsessive-compulsive disorders |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request | ||
MKLA | Lapsed |